Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017.

Daskalakis, Michael; Feller, Anita; Noetzli, Jasmine; Bonadies, Nicolas; Arndt, Volker; Baerlocher, Gabriela Maria

Daskalakis, Michael; Feller, Anita; Noetzli, Jasmine; Bonadies, Nicolas; Arndt, Volker; Baerlocher, Gabriela Maria.

Afiliación

Daskalakis M; Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, 3010 Bern, Switzerland.
Feller A; Department of BioMedicalResearch (DMBR), University of Bern, Murtenstrasse 40, 3008 Bern, Switzerland.
Noetzli J; Foundation National Institute for Cancer Epidemiology and Registration (NICER), University of Zurich, Seilergraben 49, 8001 Zurich, Switzerland.
Bonadies N; National Agency for Cancer Registration (NACR) Operated by NICER, University of Zurich, 8001 Zurich, Switzerland.
Arndt V; Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, 3010 Bern, Switzerland.
Baerlocher GM; Cabinet Noetzli, Avenue de Rumine 35, 1005 Lausanne, Switzerland.
The Nicer Working Group; Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, 3010 Bern, Switzerland.

Cancers (Basel) ; 13(24)2021 Dec 14.

Article en En | MEDLINE | ID: mdl-34944892

Palabras clave

CML; incidence; mortality; relative survival; tyrosine kinase inhibitor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google